Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
People taking retatrutide, a drug being developed by Eli Lilly, lost an average of more than 70 pounds, or 28.3% of their bodyweight, over the course of 80 weeks, according to the company's preliminary report of clinical trial results
342 Simultaneously, targeting lactate signaling (e.g., HCAR1 antagonists) may prevent myeloid cell recruitment and immune evasion
-27% Original price was: 1,850 .Current price is: 1,350
Hesse, D
US$ 27.83
US$ 23.63
US$ 22.85
US$ 29.19
US$ 26.19
